325 related articles for article (PubMed ID: 36651193)
21. Serum anti-Mullerian hormone (AMH) concentration has limited prognostic value for density of primordial and primary follicles, questioning it as an accurate parameter for the ovarian reserve.
von Wolff M; Roumet M; Stute P; Liebenthron J
Maturitas; 2020 Apr; 134():34-40. PubMed ID: 32143774
[TBL] [Abstract][Full Text] [Related]
22. Prediction of premature ovarian insufficiency: foolish fallacy or feasible foresight?
Nelson SM; Anderson RA
Climacteric; 2021 Oct; 24(5):438-443. PubMed ID: 33522318
[TBL] [Abstract][Full Text] [Related]
23. Very Low Levels of Serum Anti-Müllerian Hormone as a Possible Marker for Follicle Growth in Patients with Primary Ovarian Insufficiency Under Hormone Replacement Therapy.
Kasahara Y; Osuka S; Bayasula ; Nakanishi N; Murase T; Nakamura T; Goto M; Kotani T; Iwase A; Kikkawa F
Reprod Sci; 2021 Jan; 28(1):31-36. PubMed ID: 32737737
[TBL] [Abstract][Full Text] [Related]
24. The physiology and clinical utility of anti-Mullerian hormone in women.
Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
[TBL] [Abstract][Full Text] [Related]
25. Can we predict menopause and premature ovarian insufficiency?
Laven JSE; Louwers YV
Fertil Steril; 2024 May; 121(5):737-741. PubMed ID: 38382699
[TBL] [Abstract][Full Text] [Related]
26. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
[TBL] [Abstract][Full Text] [Related]
27. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.
Moolhuijsen LME; Visser JA
J Clin Endocrinol Metab; 2020 Nov; 105(11):3361-73. PubMed ID: 32770239
[TBL] [Abstract][Full Text] [Related]
28. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles.
La Marca A; Marzotti S; Brozzetti A; Stabile G; Artenisio AC; Bini V; Giordano R; De Bellis A; Volpe A; Falorni A;
J Clin Endocrinol Metab; 2009 Oct; 94(10):3816-23. PubMed ID: 19622621
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Anti-Mullerian Hormone Levels Pre- and Post-Hematopoietic Cell Transplantation in Pediatric and Adolescent Females with Sickle Cell Disease.
George SA; Lai KW; Lewis RW; Bryson EW; Haight AE; Meacham LR
Transplant Cell Ther; 2022 Nov; 28(11):770.e1-770.e6. PubMed ID: 35995392
[TBL] [Abstract][Full Text] [Related]
30. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
[TBL] [Abstract][Full Text] [Related]
31. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.
Dólleman M; Faddy MJ; van Disseldorp J; van der Schouw YT; Messow CM; Leader B; Peeters PH; McConnachie A; Nelson SM; Broekmans FJ
J Clin Endocrinol Metab; 2013 May; 98(5):1946-53. PubMed ID: 23509105
[TBL] [Abstract][Full Text] [Related]
32. The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer.
Anderson RA; Su HI
Front Endocrinol (Lausanne); 2020; 11():574263. PubMed ID: 33117288
[TBL] [Abstract][Full Text] [Related]
33. Anti-Müllerian hormone deficiency in females with Fanconi anemia.
Sklavos MM; Giri N; Stratton P; Alter BP; Pinto LA
J Clin Endocrinol Metab; 2014 May; 99(5):1608-14. PubMed ID: 24438373
[TBL] [Abstract][Full Text] [Related]
34. The association of low ovarian reserve with cardiovascular disease risk: a cross-sectional population-based study.
de Kat AC; Verschuren WM; Eijkemans MJ; van der Schouw YT; Broekmans FJ
Hum Reprod; 2016 Aug; 31(8):1866-74. PubMed ID: 27496945
[TBL] [Abstract][Full Text] [Related]
35. AMH and AMHR2 genetic variants in Chinese women with primary ovarian insufficiency and normal age at natural menopause.
Qin C; Yuan Z; Yao J; Zhu W; Wu W; Xie J
Reprod Biomed Online; 2014 Sep; 29(3):311-8. PubMed ID: 24912417
[TBL] [Abstract][Full Text] [Related]
36. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
37. Anti-Mullerian hormone - a marker of upcoming menopause or a questionable guesswork?
Warzecha D; Szymusik I; Pietrzak B; Wielgos M
Neuro Endocrinol Lett; 2017 May; 38(2):75-82. PubMed ID: 28650599
[TBL] [Abstract][Full Text] [Related]
38. Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women?
Grynberg M; Labrosse J; Bennani Smires B; Sifer C; Peigne M; Sonigo C
Hum Reprod; 2021 Jun; 36(7):1941-1947. PubMed ID: 34037751
[TBL] [Abstract][Full Text] [Related]
39. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
40. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study.
Bertone-Johnson ER; Manson JE; Purdue-Smithe AC; Steiner AZ; Eliassen AH; Hankinson SE; Rosner BA; Whitcomb BW
Hum Reprod; 2018 Jun; 33(6):1175-1182. PubMed ID: 29659835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
